[Initial diagnosis of Parkinson's disease - neuroradiological diagnosis]

Rinsho Shinkeigaku. 2013;53(11):977-80. doi: 10.5692/clinicalneurol.53.977.
[Article in Japanese]

Abstract

Brain MRI is essential for differentiating Parkinson's disease (PD) from other parkinsonian syndromes. The purpose of performing brain MRI is not to make a diagnosis of PD but is to exclude other parkinsonian syndromes. Recently, several new MRI techniques such as voxel based morphometry, relaxometry, magnetization transfer, spectroscopy, tractography, and functional MRI have been introduced in the diagnosis of PD. Neuromelanin imaging is one of the new techniques and can be useful to make an initial diagnosis of PD. MIBG myocardial scintigraphy is a sensitive imaging tool to differentiate PD from other parkinsonian syndromes and is one of the good tools to make an initial diagnosis of PD. Brain perfusion imaging is sometimes useful to make an initial diagnosis of PD, because reduced brain perfusion area can be detected before brain MRI detects morphological changes of the brain. Dopamine transporter imaging, not available in Japan, is a sensitive tool to detect very early parkinsonism and is useful to make an initial diagnosis of PD. However, it is difficult to differentiate PD from other parkinsonian syndromes.

Publication types

  • English Abstract
  • Review

MeSH terms

  • 3-Iodobenzylguanidine
  • Brain / blood supply
  • Brain / pathology
  • Cerebrovascular Circulation
  • Delayed Diagnosis
  • Diffusion Magnetic Resonance Imaging
  • Dopamine Plasma Membrane Transport Proteins
  • Early Diagnosis*
  • Humans
  • Magnetic Resonance Imaging / methods
  • Magnetic Resonance Imaging / trends
  • Melanins
  • Molecular Imaging
  • Myocardial Perfusion Imaging
  • Neuroimaging
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / pathology
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Melanins
  • neuromelanin
  • 3-Iodobenzylguanidine